Pioneering
Microbiome Therapeutics

Company

Carbiotix is an award winning pre-clinical stage therapeutics company leveraging low-cost gut health testing and microbiome modulators to unlock the potential of the gut microbiome to address a range of chronic and metabolic diseases.

Read More »

Gut Health Testing

Gut health testing

Carbiotix low-cost gut health test products are offered to consumers and companies as a means to cost effectively track gut health over time and overcome the natural variability associated with gut microbiome testing. The gut health tests serve as both a therapeutic discovery and diagnostic platform as well as assist with verifying and amplifying the efficacy of Carbiotix therapeutics.

See Products »

Microbiome Therapeutics

Microbiome Therapeutics

Carbiotix is developing a new generation of microbiome modulators based on proprietary second-generation soluble fibers, isolated bacterial strains and novel delivery mechanisms. This approach will allow Carbiotix to target a broad range of chronic and metabolic conditions by optimizing a person’s microbiome metabolic profile with high efficacy propriety therapeutic solutions.

See Therapies »

Track your gut health every month

Products

Microbiome sample box

OneGut™

A one-time gut health test aimed at those who are interested in better understanding their gut health

Read more »
Microbiome sample box

MonthGut™

A monthly test that allows you to track your gut health over time and see the impact of dietary and lifestyle changes

Read more »
Linkgut

LinkGut™

A service that allows food & beverage and supplement companies to build greater brand loyalty and increase sales

Read more »
Available worldwide

Gut health starts with fiber

Therapies

It is the belief of Carbiotix that activity within the gut microbiome is more important than the presence of specific bacteria species. As such, the company is focused on engineering microbiome modulators to restore and optimize gut microbiome metabolic processes and thereby obtain a desired therapeutic effect through an improved metabolic profile.

Microbiome modulater graph

Unlocking the potential of fiber

Investors

Carbiotix is a public pre-clinical stage therapeutics company leveraging low-cost gut health testing and microbiome modulators to unlock the potential of the gut microbiome to address a range of chronic and metabolic diseases.

Financial Calendar

Jan 01 - Dec 31, 2019

Current fiscal period


Nov 14, 2019

January - September 2019


Feb 12, 2020

Bokslutskommuniké för 2019


Full financial calendar »

Stock

Latest price: 7.02 SEK
Updated at: Nov 20, 2019, 14:10